Adeboye O. Osunkoya, MD

Role

Pathology
Specialty

Bladder Cancer Kidney (Renal) Cancer Penile Cancer Prostate Cancer Testicular Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2006

Biography

A nationally and internationally recognized expert, Adeboye O. Osunkoya, MD, specializes in urological and genitourinary pathology and the diagnosis of bladder, kidney, testicular and prostate cancers at Winship Cancer Institute of Emory University in Atlanta, Georgia. Dr. Osunkoya began practicing at Emory Healthcare in 2007 and has been board certified in pathology since 2006.

Titles & Roles

Professor, Departments of Pathology and Laboratory Medicine, and Urology

Emory University School of Medicine

Education & Training

Education

Fellowship, Pathology, 2007
Johns Hopkins University
Residency, Anatomic & Clinical Pathology, 2006
University of Oklahoma College of Medicine
Internship, Pathology, 2002
Univ of Ibadan Affiliated Hospitals-NIG
Medical Education, MD, 1998
University of Ibadan, College of Medicine

Board Certifications

Anatomic Pathology
American Board of Pathology, 2006
Clinical Pathology
American Board of Pathology, 2006

Professional Memberships

Dr. Osunkoya has served on the editorial boards of the academic journals Archives of Pathology and Laboratory Medicine, Pathology, Human Pathology, and International Journal of Clinical and Experimental Pathology. He has also served on the abstract review board of the College of American Pathologists, on the Education Committee of the United States and Canadian Academy of Pathology, and as Chair of the Excellence in Urological Pathology Resident and Fellow Research Award Committee of the International Society of Urological Pathology.

Dr. Osunkoya is a member of the American Society for Clinical Pathology, the College of American Pathologists, and the International Society of Urological Pathology.

Dr. Osunkoya served as president of the United States and Canadian Academy of Pathology (2023-2024).

Research

Dr. Osunkoya's research interests include the fields of genitourinary and urologic pathology, specifically tumors of the prostate, urinary bladder, kidneys, and testis.

Publications

Dr. Osunkoya has been published over 200 times in a variety of academic journals including the Modern Pathology, Human Pathology, American Journal of Surgical Pathology, Pathology, and Urology. He has also authored or co-authored 25 book chapters and has a plethora of other publications.

Dr. Osunkoya has been named to the MilliPub Club, which recognizes current Emory University School of Medicine faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.

Title/Journal	Authors	Publication Date
Wilms Tumor: An Unexpected Diagnosis in Adult Patients. Archives of pathology & laboratory medicine	GJ Chan, BA Stohr, AO Osunkoya, NA Croom, SJ Cho, R Balassanian, V Charu, GR Bean, E Chan	06/01/2024
Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts. The Journal of clinical investigation	B Zhang, M Liu, F Mai, X Li, W Wang, Q Huang, X Du, W Ding, Y Li, B Barwick, J Ni, A Osunkoya, Y Chen, W Zhou, S Xia, JT Dong	05/23/2024
A Contemporary Clinicopathologic Analysis of Patients With Renal Cell Carcinoma and Vena Cava Involvement. International journal of surgical pathology	OM Al-Rusan, D Patil, VA Master, AO Osunkoya	04/01/2024
Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients. Pathology, research and practice	A Alrohaibani, AO Osunkoya	04/01/2024
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Cancer	BN Schmeusser, DH Patil, EH Nicaise, M Armas-Phan, R Nabavizadeh, VM Narayan, SS Joshi, K Ogan, AO Osunkoya, MA Bilen, VA Master	02/01/2024
Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior. The Journal of pathology	S Gupta, LM Sholl, Y Yang, AO Osunkoya, JB Gordetsky, KM Cornejo, K Michalova, F Maclean, E Dvindenko, M Snuderl, MS Hirsch, WJ Anderson, RA Rowsey, RE Jimenez, JC Cheville, PM Sadow, M Colecchia, C Ricci, TM Ulbright, DM Berney, AM Acosta	01/01/2024
Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	M Aron, DS Chandrashekar, S Canete-Portillo, F Brimo, SR Williamson, AO Osunkoya, MR Raspollini, LP Kunju, S Varambally, AC Mackinnon, S Harada, GJ Netto	12/01/2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. Cancers	CS Moreno, CL Winham, M Alemozaffar, ER Klein, IO Lawal, OA Abiodun-Ojo, D Patil, BG Barwick, Y Huang, DM Schuster, MG Sanda, AO Osunkoya	11/30/2023
A Contemporary Clinicopathologic Analysis of Primary Sarcomas of the Perinephric Soft Tissue and Hilar Vessels Including a Subset Secondarily Involving the Kidney. International journal of surgical pathology	AN Scheiderer, A Bahrami, VA Master, AO Osunkoya	10/01/2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. British journal of cancer	X Li, Y Chen, L Bai, R Zhao, Y Wu, ZR Xie, JM Wu, NJ Bowen, A Danaher, N Cook, D Li, M Qui, Y Du, H Fu, AO Osunkoya, O Kucuk, D Wu	09/01/2023
Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists. International journal of surgical pathology	SK Mohanty, A Lobo, SR Williamson, RB Shah, K Trpkov, M Varma, D Sirohi, M Aron, SR Kandukari, BL Balzer, DL Luthringer, J Ro, AO Osunkoya, S Desai, S Menon, LK Nigam, R Sardana, P Roy, S Kaushal, D Midha, M Swain, A Ambekar, S Mitra, V Rao, S Soni, K Jain, P Diwaker, N Pattnaik, S Sharma, I Chakrabarti, M Sable, E Jain, D Jain, S Samra, M Vankalakunti, S Mohanty, AV Parwani, S Sancheti, N Kumari, S Jha, M Dixit, V Malik, S Arora, G Munjal, A Gopalan, C Magi-Galluzzi, J Dhillon	09/01/2023
Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	L Cheng, A Lopez-Beltran, M Wang, RD Whaley, A De Souza, S Au, R Ge, A Cimadamore, A Amin, B Golijanin, GT MacLennan, AO Osunkoya, R Montironi, S Zhang	07/01/2023
DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. Cancer research	J Gallon, A Rodriguez-Calero, A Benjak, D Akhoundova, S Maletti, U Amstutz, E Hewer, V Genitsch, A Fleischmann, EJ Rushing, R Grobholz, I Fischer, W Jochum, G Cathomas, AO Osunkoya, L Bubendorf, H Moch, G Thalmann, FY Feng, S Gillessen, CKY Ng, MA Rubin, S Piscuoglio	04/14/2023
Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Human pathology	R Mannan, X Wang, PS Bawa, S Chugh, AK Chinnaiyan, R Rangaswamy, Y Zhang, X Cao, SC Smith, K Trpkov, SR Williamson, AR Sangoi, S Mohanty, JK McKenney, S Gupta, C Magi-Galluzzi, P Argani, AO Osunkoya, AM Chinnaiyan, SM Dhanasekaran, R Mehra	04/01/2023
Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology. Journal of clinical pathology	P Mullane, S Joshi, M Bilen, AO Osunkoya	04/01/2023
Radical prostatectomy findings in patients with locally aggressive Grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection. Pathology, research and practice	SS Mallikarjunappa, AO Osunkoya	04/01/2023
Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus. Journal of immunotherapy and precision oncology	VA Master, BN Schmeusser, AO Osunkoya, AR Palacios, E Midenberg, L Yantorni, K Ogan, MA Bilen	02/01/2023
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022). Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	R Alaghehbandan, A Agaimy, L Ali, I Alvarado-Cabrero, MB Amin, L Boudova, A Caliò, EM Comperat, I Damjanov, O Daum, M Farcas, Z Gatalica, AJ Gill, A Hartmann, MM Hayes, M Hora, F Kojima, G Kristiansen, N Kuroda, JI López, F Maclean, C Magi-Galluzzi, G Martignoni, JK McKenney, K Michalová, M Michal, SK Mohanty, GJ Netto, R Ohashi, O Ondič, AO Osunkoya, MDPM Gomez, F Petersson, MM Picken, K Pivovarcikova, J Rogala, RB Shah, F Siadat, F Skenderi, M Sperga, SM Suster, M Svajdler, M Tretiakova, K Trpkov, M Ulamec, SR Williamson, XJ Yang, M Zhou, S Vranic, G Vujanic, M Michal	12/01/2022
GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall. Diagnostic pathology	M Akgul, R Humble, A Osme, S Yuce, EN Kocak, P Najafzadeh, A Sangoi, N Pattnaik, S Mishra, S Sharma, N Shaker, S Kaushal, M Baisakh, AR Lightle, BL Balzer, GQ Xiao, GT MacLennan, AO Osunkoya, A Parwani, L Cheng, A Bellizzi, SK Mohanty	11/01/2022
Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study. Human pathology	BA Stohr, E Chan, JA Anderson, A Matoso, BI Murati Amador, L Cheng, AO Osunkoya	11/01/2022
Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study. Annals of diagnostic pathology	J Kolar, AF Llaurado, M Ulamec, F Skenderi, D Perez-Montiel, I Alvarado-Cabrero, S Bulimbasic, M Sperga, M Tretiakova, AO Osunkoya, J Rogala, E Comperat, V Gal, A Dunatov, K Pivovarcikova, K Michalova, AB Vesela, M Slisarenko, AP Strakova, T Pitra, M Hora, M Michal, R Alaghehbandan, O Hes	10/01/2022
Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patients. Histopathology	AM Acosta, AR Sangoi, F Maclean, K Trpkov, AO Osunkoya, K Collins, H Miyamoto, MS Hirsch, E Chan, M Tretiakova, SK Mohanty, S Kaushal, KM Cornejo, M Aron, G Quiroga-Garza, K Arora, JK Nguyen, SR Williamson, JI Epstein, A Matoso	10/01/2022
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	KI Al-Obaidy, RM Saleeb, K Trpkov, SR Williamson, AR Sangoi, M Nassiri, O Hes, R Montironi, A Cimadamore, AM Acosta, ZI Alruwaii, A Alkashash, O Hassan, N Gupta, AO Osunkoya, JD Sen, LA Baldrige, WA Sakr, MT Idrees, JN Eble, DJ Grignon, L Cheng	09/01/2022
Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases. The American journal of surgical pathology	AM Acosta, JB Gordetsky, K Collins, AO Osunkoya, AR Sangoi, H Miyamoto, CS Kao, K Trpkov, GJLH Van Leenders, SE Wobker, F Maclean, P Lal, RE Daniel, F Brimo, M Wasco, MS Hirsch, N Baniak, JA Diaz-Perez, KM Cornejo, B Choy, R Mehra, SR Williamson, JI Epstein, A Matoso	09/01/2022
Secondary Tumors of the Kidney: A Comprehensive Clinicopathologic Analysis. Advances in anatomic pathology	F Saeed, AO Osunkoya	07/01/2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood. Journal for immunotherapy of cancer	JW Carlisle, CS Jansen, MA Cardenas, E Sobierajska, AM Reyes, R Greenwald, L Del Balzo, N Prokhnevska, O Kucuk, BC Carthon, PC Mullane, A Osunkoya, D Baumgarten, F Hosseinzadeh, S Wilkinson, R Lake, AG Sowalsky, Y Liu, VA Master, MA Bilen, H Kissick	07/01/2022
Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic virtual stains. Scientific reports	S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai, AO Osunkoya, FE Robles	06/04/2022
Histopathologic findings in patients who have undergone blue light cystoscopy and bladder biopsy or transurethral resection: A contemporary clinicopathologic analysis of 100 cases. Pathology, research and practice	J Singh, S Farooq, S Joshi, AO Osunkoya	06/01/2022
Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nature communications	A Rodriguez-Calero, J Gallon, D Akhoundova, S Maletti, A Ferguson, J Cyrta, U Amstutz, A Garofoli, V Paradiso, SA Tomlins, E Hewer, V Genitsch, A Fleischmann, E Vassella, EJ Rushing, R Grobholz, I Fischer, W Jochum, G Cathomas, AO Osunkoya, L Bubendorf, H Moch, G Thalmann, CKY Ng, S Gillessen, S Piscuoglio, MA Rubin	05/03/2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	V Ouellet, A Erickson, K Wiley, C Morrissey, V Berge, CS Moreno, KA Tasken, D Trudel, LD True, MS Lewis, A Svindland, O Ertunc, ID Vidal, AO Osunkoya, T Jones, GS Bova, T Lamminen, AH Achtman, M Buzza, MM Kouspou, SA Bigler, X Zhou, SJ Freedland, AM Mes-Masson, IP Garraway, BJ Trock, P Taimen, F Saad, T Mirtti, BS Knudsen, AM De Marzo	04/01/2022
Poorly Differentiated Scrotal Carcinoma With Apocrine Immunophenotype. The American Journal of dermatopathology	S Kamanda, JI Epstein, AO Osunkoya, A Cimino-Mathews, P Argani, M Sangüeza, JA Plaza, A Matoso	04/01/2022
A Contemporary Clinicopathologic Analysis of Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral, or Bladder Carcinoma. International journal of surgical pathology	F Chen, S Joshi, BC Carthon, AO Osunkoya	02/01/2022
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	MDC Rodriguez Pena, S Canete-Portillo, A Amin, M Aron, P Colombo, R Cox, DE Baydar, I Gallegos, F Khani, K Michalova, R Lucianò, H Miyamoto, AO Osunkoya, MR Raspollini, DF Sánchez, F Scarfo, JS So, DL Zynger, S Wei, GJ Netto, C Magi-Galluzzi	02/01/2022
Deep UV Microscopy Identifies Prostatic Basal Cells: An Important Biomarker for Prostate Cancer Diagnostics. BME frontiers	S Soltani, B Cheng, AO Osunkoya, FE Robles	01/01/2022
Secondary malignancy after urologic reconstruction procedures: a multi-institutional case series. Human pathology	C Cornell, F Khani, AO Osunkoya, A Matoso, H Miyamoto, JB Gordetsky, SN Salaria, GA Giannico	01/01/2022
Skene gland adenocarcinoma: Clinicopathologic features, comprehensive biomarker analysis, and review of the literature. Pathology international	F Saeed, AO Osunkoya	10/01/2021
Primary urothelial carcinoma of the ureter without concurrent renal pelvic or bladder carcinoma: A contemporary clinicopathologic analysis. Pathology, research and practice	CM Gutierrez, BC Carthon, S Joshi, AO Osunkoya	10/01/2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database. Clinical genitourinary cancer	KM Xu, Y Liu, TW Gillespie, AO Osunkoya, B Carthon, MA Bilen, CP Filson, K Ogan, PR Patel, JW Shelton, O Kucuk, S Joshi, AB Jani	08/01/2021
Metastatic urothelial carcinoma to the brain, spinal cord and spine: A contemporary multi-institutional clinicopathologic analysis of 24 cases. Pathology, research and practice	OB Ogunbona, A Matoso, L Cheng, S Shen, SZ Powell, AO Osunkoya	08/01/2021
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Advances in anatomic pathology	MB Amin, E Comperat, JI Epstein, LD True, D Hansel, GP Paner, H Al-Ahmadie, D Baydar, T Bivalacqua, F Brimo, L Cheng, J Cheville, G Dalbagni, S Falzarano, J Gordetsky, CC Guo, S Gupta, O Hes, G Iyer, S Kaushal, L Kunju, C Magi-Galluzzi, A Matoso, G Netto, AO Osunkoya, CC Pan, K Pivovarcikova, MR Raspollini, H Reis, J Rosenberg, M Roupret, RB Shah, S Shariat, K Trpkov, V Weyerer, M Zhou, J McKenney, VE Reuter	07/01/2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Advances in anatomic pathology	E Compérat, MB Amin, JI Epstein, DE Hansel, G Paner, H Al-Ahmadie, L True, D Bayder, T Bivalacqua, F Brimo, L Cheng, J Cheville, G Dalbagni, S Falzarano, J Gordetsky, C Guo, S Gupta, O Hes, G Iyer, S Kaushal, L Kunju, C Magi-Galluzzi, A Matoso, J McKenney, GJ Netto, AO Osunkoya, CC Pan, K Pivovarcikova, MR Raspollini, H Reis, J Rosenberg, M Roupret, RB Shah, SF Shariat, K Trpkov, V Weyerer, M Zhou, V Reuter	07/01/2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. Journal of clinical pathology	M Akgul, SR Williamson, D Ertoy, P Argani, S Gupta, A Caliò, V Reuter, S Tickoo, HA Al-Ahmadie, GJ Netto, O Hes, MS Hirsch, B Delahunt, R Mehra, S Skala, AO Osunkoya, L Harik, P Rao, AR Sangoi, M Nourieh, DL Zynger, SC Smith, T Nazeer, B Gumuskaya, I Kulac, F Khani, MS Tretiakova, F Vakar-Lopez, G Barkan, V Molinié, V Verkarre, Q Rao, L Kis, A Panizo, T Farzaneh, MJ Magers, J Sanfrancesco, C Perrino, D Gondim, R Araneta, JS So, JY Ro, M Wasco, O Hameed, A Lopez-Beltran, H Samaratunga, SE Wobker, J Melamed, L Cheng, MT Idrees	05/01/2021
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. Urologic oncology	SW Fine, K Trpkov, MB Amin, F Algaba, M Aron, DE Baydar, AL Beltran, F Brimo, JC Cheville, M Colecchia, E Comperat, T Costello, IW da Cunha, W Delprado, AM DeMarzo, GA Giannico, JB Gordetsky, CC Guo, DE Hansel, MS Hirsch, J Huang, PA Humphrey, RE Jimenez, F Khani, MX Kong, ON Kryvenko, LP Kunju, P Lal, M Latour, T Lotan, F Maclean, C Magi-Galluzzi, R Mehra, S Menon, H Miyamoto, R Montironi, GJ Netto, JK Nguyen, AO Osunkoya, A Parwani, CP Pavlovich, BD Robinson, MA Rubin, RB Shah, JS So, H Takahashi, F Tavora, MS Tretiakova, L True, SE Wobker, XJ Yang, M Zhou, DL Zynger, JI Epstein	05/01/2021
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Archives of pathology & laboratory medicine	JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, F Brimo, JC Cheville, M Colecchia, E Comperat, IW da Cunha, W Delprado, AM DeMarzo, GA Giannico, JB Gordetsky, CC Guo, DE Hansel, MS Hirsch, J Huang, PA Humphrey, RE Jimenez, F Khani, Q Kong, ON Kryvenko, LP Kunju, P Lal, M Latour, T Lotan, F Maclean, C Magi-Galluzzi, R Mehra, S Menon, H Miyamoto, R Montironi, GJ Netto, JK Nguyen, AO Osunkoya, A Parwani, BD Robinson, MA Rubin, RB Shah, JS So, H Takahashi, F Tavora, MS Tretiakova, L True, SE Wobker, XJ Yang, M Zhou, DL Zynger, K Trpkov	04/01/2021
Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis. International journal of surgical pathology	J Kagan, M Alemozaffar, B Carthon, AO Osunkoya	04/01/2021
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nature communications	B Zhang, Y Li, Q Wu, L Xie, B Barwick, C Fu, X Li, D Wu, S Xia, J Chen, WP Qian, L Yang, AO Osunkoya, L Boise, PM Vertino, Y Zhao, M Li, HR Chen, J Kowalski, O Kucuk, W Zhou, JT Dong	03/17/2021
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study. Pathology	JA Anderson, A Matoso, BI Murati Amador, L Cheng, BA Stohr, E Chan, AO Osunkoya	02/01/2021
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations. American journal of cancer research	RB Shah, Q Cai, M Aron, DM Berney, JC Cheville, FM Deng, J Epstein, SW Fine, EM Genega, MS Hirsch, PA Humphrey, J Gordetsky, G Kristiansen, LP Kunju, C Magi-Galluzzi, N Gupta, GJ Netto, AO Osunkoya, BD Robinson, K Trpkov, LD True, P Troncoso, M Varma, T Wheeler, SR Williamson, A Wu, M Zhou	01/01/2021
Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model. American journal of clinical and experimental urology	D Wu, AO Osunkoya, O Kucuk	01/01/2021
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database. Clinical and translational radiation oncology	JR Janopaul-Naylor, J Zhong, Y Liu, C Zhang, AO Osunkoya, SS Joshi, MA Bilen, B Carthon, O Kucuk, LM Hartsell, J Shelton, AB Jani	01/01/2021
Metastatic prostatic adenocarcinoma to the brain and spinal cord: a contemporary clinicopathologic analysis of 30 cases. International journal of clinical and experimental pathology	OB Ogunbona, AL Goodman, AO Osunkoya	01/01/2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer. Theranostics	X Li, L Gera, S Zhang, Y Chen, L Lou, LM Wilson, ZR Xie, G Sautto, D Liu, A Danaher, K Mamouni, Y Yang, Y Du, H Fu, O Kucuk, AO Osunkoya, J Zhou, D Wu	01/01/2021
Genital verruciform xanthoma: lessons from a contemporary multi-institutional series. Histopathology	G Wang, MC Mochel, MB Randall, JS Gandhi, AM Udager, MP Chan, RM Patel, MB Amin, AO Osunkoya, SC Smith	11/01/2020
[¹⁸F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer. The Journal of urology	M Alemozaffar, AA Akintayo, OA Abiodun-Ojo, D Patil, F Saeed, Y Huang, AO Osunkoya, MM Goodman, M Sanda, DM Schuster	10/01/2020
In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers. Radiology. Imaging cancer	KK Elfatairy, CP Filson, MG Sanda, AO Osunkoya, SG Nour	09/25/2020
Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis. International journal of urology : official journal of the Japanese Urological Association	RC Obeng, RS Arnold, K Ogan, VA Master, JG Pattaras, JA Petros, AO Osunkoya	09/01/2020
Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States. Applied immunohistochemistry & molecular morphology : AIMM	M Shabihkhani, P Patil, B Murati Amador, JA Plaza, AO Osunkoya, KA Lombardo, JI Epstein, A Matoso	08/01/2020
A Rare Case of Vena Cava Tumor Thrombus Associated With Epithelioid Angiomyolipoma. Urology	G Lee, R Nabavizadeh, AO Osunkoya, VA Master	08/01/2020
PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	AS Taylor, JK McKenney, AO Osunkoya, MP Chan, HA Al-Ahmadie, DE Spratt, DR Fullen, AM Chinnaiyan, NA Brown, R Mehra	06/01/2020
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. The American journal of surgical pathology	JS Gandhi, SC Smith, GP Paner, JK McKenney, R Sekhri, AO Osunkoya, AS Baras, AM DeMarzo, JC Cheville, RE Jimenez, K Trpkov, M Colecchia, JY Ro, R Montironi, S Menon, O Hes, SR Williamson, MS Hirsch, GJ Netto, SW Fine, D Sirohi, S Kaushal, A Sangoi, BD Robinson, CF Kweldam, PA Humphrey, DE Hansel, L Schultz, C Magi-Galluzzi, CG Przybycin, RB Shah, R Mehra, LP Kunju, M Aron, ON Kryvenko, JG Kench, N Kuroda, F Tavora, T van der Kwast, DJ Grignon, JI Epstein, VE Reuter, MB Amin	05/01/2020
The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression. Translational oncology	Z Li, C Sun, S Tao, AO Osunkoya, RS Arnold, JA Petros, X Zu, CS Moreno	04/01/2020
Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration. Nature communications	B Zhang, X Ci, R Tao, JJ Ni, X Xuan, JL King, S Xia, Y Li, HF Frierson, DK Lee, J Xu, AO Osunkoya, JT Dong	02/21/2020
Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture. Annals of diagnostic pathology	K Michalova, M Tretiakova, K Pivovarcikova, R Alaghehbandan, D Perez Montiel, M Ulamec, A Osunkoya, K Trpkov, G Yuan, P Grossmann, M Sperga, I Ferak, J Rogala, J Mareckova, T Pitra, J Kolar, M Michal, O Hes	02/01/2020
Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features. Applied immunohistochemistry & molecular morphology : AIMM	W Zheng, AL Goodman, JE Velázquez Vega, F Yin, KM Fung, AO Osunkoya	01/01/2020
Steroid Receptor Coactivator-1 Expression in Pheochromocytoma: Clinicopathologic Correlation and Potential Diagnostic Pitfall. Applied immunohistochemistry & molecular morphology : AIMM	MJ Xiong, AO Osunkoya	01/01/2020
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature	CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, M Cardenas, S Wilkinson, R Lake, AG Sowalsky, RM Valanparambil, WH Hudson, D McGuire, K Melnick, AI Khan, K Kim, YM Chang, A Kim, CP Filson, M Alemozaffar, AO Osunkoya, P Mullane, C Ellis, R Akondy, SJ Im, AO Kamphorst, A Reyes, Y Liu, H Kissick	12/01/2019
¹⁸F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AA Akintayo, OO Akin-Akintayo, FI Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, B Fei, DM Schuster	11/01/2019
MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	MJ Magers, KA Iczkowski, R Montironi, DJ Grignon, S Zhang, SR Williamson, X Yang, M Wang, AO Osunkoya, A Lopez-Beltran, O Hes, JN Eble, L Cheng	11/01/2019
In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI. Radiology. Imaging cancer	KK Elfatairy, CP Filson, MG Sanda, AO Osunkoya, SG Nour	11/01/2019
Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases. Human pathology	CM Gutierrez, M Alemozaffar, AO Osunkoya	10/01/2019
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer. The Journal of urology	B Fei, OA Abiodun-Ojo, AA Akintayo, O Akin-Akintayo, F Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, DM Schuster	08/01/2019
Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma. European urology focus	DS Priemer, M Wang, S Zhang, A Lopez-Beltran, E Kouba, R Montironi, DD Davidson, GT MacLennan, L Wang, AO Osunkoya, Y Deng, RE Emerson, L Cheng	12/01/2018
Benign vascular tumors, cysts, and pseudocysts of the adrenal gland: a contemporary multi-institutional clinicopathological analysis of 55 cases. Human pathology	W Zheng, KM Fung, L Cheng, AO Osunkoya	12/01/2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney. The American journal of surgical pathology	L Wang, Y Zhang, YB Chen, SL Skala, HA Al-Ahmadie, X Wang, X Cao, BA Veeneman, J Chen, M Cieślik, Y Qiao, F Su, P Vats, J Siddiqui, H Xiao, ET Sadimin, JI Epstein, M Zhou, AR Sangoi, K Trpkov, AO Osunkoya, GA Giannico, JK McKenney, P Argani, SK Tickoo, VE Reuter, AM Chinnaiyan, SM Dhanasekaran, R Mehra	12/01/2018
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists	O Fadare, MM Desouki, K Gwin, KZ Hanley, EA Jarboe, SX Liang, CM Quick, KR Rawish, AA Roma, W Zheng, JL Hecht, V Parkash, AO Osunkoya	11/01/2018
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer. Cancers	NV Sharma, KL Pellegrini, V Ouellet, FO Giuste, S Ramalingam, K Watanabe, E Adam-Granger, L Fossouo, S You, MR Freeman, P Vertino, K Conneely, AO Osunkoya, D Trudel, AM Mes-Masson, JA Petros, F Saad, CS Moreno	10/11/2018
Selective modification of fluciclovine (¹⁸F) transport in prostate carcinoma xenografts. Amino acids	FI Tade, WG Wiles, G Lu, B Bilir, O Akin-Akintayo, JS Lee, D Patil, W Yu, C Ormenisan Gherasim, B Fei, CS Moreno, AO Osunkoya, EJ Teoh, S Oka, H Okudaira, MM Goodman, DM Schuster	09/01/2018
Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European journal of radiology	O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, R Halkar, B Fei, V Master, AB Jani, H Kitajima, AO Osunkoya, C Ormenisan-Gherasim, MM Goodman, DM Schuster	05/01/2018
PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 Cases. Applied immunohistochemistry & molecular morphology : AIMM	EC Bertsch, C Magi-Galluzzi, L Cheng, AO Osunkoya	04/01/2018
In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study. The British journal of radiology	KK Elfatairy, CP Filson, MG Sanda, AO Osunkoya, RL Geller, SG Nour	04/01/2018
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. The American journal of surgical pathology	C Ohe, SC Smith, D Sirohi, M Divatia, M de Peralta-Venturina, GP Paner, A Agaimy, MB Amin, P Argani, YB Chen, L Cheng, M Colecchia, E Compérat, I Werneck da Cunha, JI Epstein, AJ Gill, O Hes, MS Hirsch, W Jochum, LP Kunju, F Maclean, C Magi-Galluzzi, JK McKenney, R Mehra, G Nesi, AO Osunkoya, MM Picken, P Rao, VE Reuter, PG de Oliveira Salles, L Schultz, SK Tickoo, SA Tomlins, K Trpkov, MB Amin	03/01/2018
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	SL Skala, H Xiao, AM Udager, SM Dhanasekaran, S Shukla, Y Zhang, C Landau, L Shao, D Roulston, L Wang, J Siddiqui, X Cao, C Magi-Galluzzi, M Zhang, AO Osunkoya, SC Smith, JK McKenney, BL Betz, JL Myers, AM Chinnaiyan, SA Tomlins, R Mehra	01/01/2018
Mucinous and secondary tumors of the prostate. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	AO Osunkoya	01/01/2018
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma. Oncoimmunology	KS Kim, RR Sekar, D Patil, MA Dimarco, HT Kissick, MA Bilen, AO Osunkoya, VA Master	01/01/2018
Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3? The American journal of surgical pathology	J Gordetsky, J Sanfrancesco, JI Epstein, K Trevino, H Xu, A Osunkoya, GQ Xiao, CS Kao, P Unger, N Hashemi-Sadraei, C Albany, JM Jorns, DY Lu, A Matoso, S Rais-Bahrami, LE Schwartz, TM Ulbright, MT Idrees	10/01/2017
Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity. The American journal of surgical pathology	K Trpkov, H Abou-Ouf, O Hes, JI Lopez, G Nesi, E Comperat, M Sibony, AO Osunkoya, M Zhou, N Gokden, X Leroy, DM Berney, I Werneck Cunha, ML Musto, DA Athanazio, A Yilmaz, B Donnelly, E Hyndman, AJ Gill, JK McKenney, TA Bismar	10/01/2017
Cytologic predictors of malignancy in bile duct brushings: a multi-reviewer analysis of 60 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	V Avadhani, E Hacihasanoglu, B Memis, B Pehlivanoglu, KZ Hanley, U Krishnamurti, AM Krasinskas, AO Osunkoya, LM Daniels, AA Freedman, M Goodman, V Adsay, MD Reid	09/01/2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation. Oncotarget	A Caliò, JN Eble, O Hes, G Martignoni, SE Harari, SR Williamson, M Brunelli, AO Osunkoya, L Wang, E Comperat, A Lopez-Beltran, M Wang, S Zhang, KL Curless, KM Post, HY Chang, C Luchini, LA Baldrige, GT MacLennan, R Montironi, DJ Grignon, L Cheng	08/15/2017
Urothelial carcinoma involving the ureteral orifice: a clinicopathologic analysis of 93 cases. Human pathology	AC Annan, KA Stevens, AO Osunkoya	07/01/2017
Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene. Journal of clinical pathology	E Kouba, NB Simper, S Chen, SR Williamson, DJ Grignon, JN Eble, GT MacLennan, R Montironi, A Lopez-Beltran, AO Osunkoya, S Zhang, M Wang, L Wang, T Tran, RE Emerson, LA Baldrige, MF Monn, K Linos, L Cheng	06/01/2017
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master	06/01/2017
Biomarker, Molecular, and Technologic Advances in Urologic Pathology, Oncology, and Imaging. Archives of pathology & laboratory medicine	CL Ellis, LR Harik, C Cohen, AO Osunkoya	04/01/2017
TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract. Future oncology (London, England)	X Wang, A Lopez-Beltran, AO Osunkoya, M Wang, S Zhang, DD Davidson, RE Emerson, SR Williamson, PH Tan, HZ Kaimakliotis, LA Baldridge, GT MacLennan, R Montironi, L Cheng	04/01/2017
Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall. Applied immunohistochemistry & molecular morphology : AIMM	KZ Hanley, C Cohen, AO Osunkoya	02/01/2017
Molecular imaging and fusion targeted biopsy of the prostate. Clinical and translational imaging	B Fei, PT Nieh, VA Master, Y Zhang, AO Osunkoya, DM Schuster	02/01/2017
Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. Cancer discovery	R Mehra, P Vats, M Cieslik, X Cao, F Su, S Shukla, AM Udager, R Wang, J Pan, K Kasaian, R Lonigro, J Siddiqui, K Premkumar, G Palapattu, A Weizer, KS Hafez, JS Wolf, AR Sangoi, K Trpkov, AO Osunkoya, M Zhou, G Giannico, JK McKenney, SM Dhanasekaran, AM Chinnaiyan	11/01/2016
Human epidermal growth factor receptor 2 expression in micropapillary urothelial carcinoma of the bladder: an analysis of 27 cases. Human pathology	AL Goodman, AO Osunkoya	11/01/2016
Surgical Management of Primary Scrotal Cancer. The Urologic clinics of North America	JH Huang, M Broggi, AO Osunkoya, VA Master	11/01/2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European journal of nuclear medicine and molecular imaging	OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, PJ Rossi, RK Halkar, AO Osunkoya, O Akin-Akintayo, C Zhang, Z Chen, MM Goodman, DM Schuster	09/01/2016
Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms. The American journal of surgical pathology	SM Falzarano, JK McKenney, R Montironi, JN Eble, AO Osunkoya, J Guo, S Zhou, H Xiao, SM Dhanasekaran, S Shukla, R Mehra, C Magi-Galluzzi	07/01/2016
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival. Asian journal of urology	RR Sekar, CM De La Calle, D Patil, SA Holzman, Y Baum, U Sheikh, JH Huang, AO Osunkoya, BP Pollack, HT Kissick, K Ogan, VA Master	04/01/2016
SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation. Cancer research	B Bilir, AO Osunkoya, WG Wiles, S Sannigrahi, V Lefebvre, D Metzger, DD Spyropoulos, WD Martin, CS Moreno	03/01/2016
Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases. Human pathology	IU Nwadei, A Lorentz, D Patil, MA Dimarco, VA Master, AO Osunkoya	03/01/2016
GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas. Human pathology	DG Davis, MT Siddiqui, G Oprea-Ilies, K Stevens, AO Osunkoya, C Cohen, XB Li	01/01/2016
Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis. Human pathology	SE Harari, L Cheng, AO Osunkoya	01/01/2016
Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. The American journal of surgical pathology	M Zhou, J Li, L Cheng, L Egevad, FM Deng, LP Kunju, C Magi-Galluzzi, J Melamed, R Mehra, S Mendrinos, AO Osunkoya, G Paner, SS Shen, T Tsuzuki, K Trpkov, W Tian, X Yang, RB Shah	10/01/2015
Pendrin localizes to the adrenal medulla and modulates catecholamine release. American journal of physiology. Endocrinology and metabolism	Y Lazo-Fernandez, G Aguilera, TD Pham, AY Park, WH Beierwaltes, RL Sutliff, JW Verlander, K Pacak, AO Osunkoya, CL Ellis, YH Kim, GL Shipley, BM Wynne, RS Hoover, SK Sen, PM Plotsky, SM Wall	09/15/2015
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment. Bone	RS Arnold, SA Fedewa, M Goodman, AO Osunkoya, HT Kissick, C Morrissey, LD True, JA Petros	09/01/2015
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma. Molecular carcinogenesis	L Wang, SR Williamson, S Zhang, J Huang, R Montironi, DD Davison, M Wang, JL Yao, A Lopez-Beltran, AO Osunkoya, GT MacLennan, LA Baldridge, X Du, L Cheng	09/01/2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists. The American journal of surgical pathology	RB Shah, J Li, L Cheng, L Egevad, FM Deng, SW Fine, LP Kunju, J Melamed, R Mehra, AO Osunkoya, GP Paner, SS Shen, T Tsuzuki, K Trpkov, W Tian, XJ Yang, M Zhou	09/01/2015
Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations. Histopathology	E Choi, SR Williamson, R Montironi, S Zhang, M Wang, JN Eble, DJ Grignon, A Lopez-Beltran, MT Idrees, LA Baldridge, M Scarpelli, CL Jones, L Wang, GT MacLennan, AO Osunkoya, L Cheng	07/01/2015
The Value of Pathological Examination of the Foreskin Following Circumcision. Urology practice	IJ Safir, AP Patel, BP Moore, D Patil, G Bellott-McGrath, AO Osunkoya, MM Issa	07/01/2015
Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR. Human pathology	NB Simper, CL Jones, GT MacLennan, R Montironi, SR Williamson, AO Osunkoya, M Wang, S Zhang, DJ Grignon, JN Eble, T Tran, L Wang, LA Baldrige, L Cheng	06/01/2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. The Canadian journal of urology	N Fatima, DJ Canter, BC Carthon, O Kucuk, VA Master, PT Nieh, K Ogan, AO Osunkoya	06/01/2015
Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics	K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk	04/15/2015
Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	HL Tan, MC Haffner, DM Esopi, AM Vaghasia, GA Giannico, HM Ross, S Ghosh, JL Hicks, Q Zheng, AR Sangoi, S Yegnasubramanian, AO Osunkoya, AM De Marzo, JI Epstein, TL Lotan	03/01/2015
Pathologic findings in patients with targeted magnetic resonance imaging-guided prostate needle core biopsies. International journal of clinical and experimental pathology	RL Geller, SG Nour, AO Osunkoya	01/01/2015
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis. Urologia internationalis	SA Holzman, CM de la Calle, HT Kissick, AO Osunkoya, BP Pollack, D Patil, K Ogan, VA Master	01/01/2015
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Annals of diagnostic pathology	KA Iczkowski, L Egevad, J Ma, N Harding-Jackson, F Algaba, A Billis, P Camparo, L Cheng, D Clouston, EM Comperat, MW Datta, AG Evans, DF Griffiths, CC Guo, S Hailemariam, W Huang, PA Humphrey, Z Jiang, H Kahane, G Kristiansen, FG La Rosa, A Lopez-Beltran, GT MacLennan, C Magi-Galluzzi, J Merrimen, R Montironi, AO Osunkoya, MM Picken, N Rao, RB Shah, JH Shanks, SS Shen, OW Tawfik, LD True, T Van der Kwast, M Varma, TM Wheeler, DL Zynger, N Sahr, DG Bostwick	12/01/2014
Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	SR Williamson, M Wang, R Montironi, JN Eble, A Lopez-Beltran, S Zhang, R Fan, L Wang, AO Osunkoya, MO Koch, L Cheng	11/01/2014
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. The American journal of surgical pathology	J Guo, MS Tretiakova, ML Troxell, AO Osunkoya, O Fadare, AR Sangoi, SS Shen, A Lopez-Beltran, R Mehra, A Heider, JP Higgins, LR Harik, X Leroy, AJ Gill, K Trpkov, SC Campbell, C Przybycin, C Magi-Galluzzi, JK McKenney	11/01/2014
Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas. The American journal of surgical pathology	A Matoso, S Chen, JA Plaza, AO Osunkoya, JI Epstein	10/01/2014
Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	L Ehsani, AO Osunkoya	09/01/2014
GATA3 expression in sarcomatoid urothelial carcinoma of the bladder. Human pathology	N Fatima, AO Osunkoya	08/01/2014
ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	TM Schneider, AO Osunkoya	08/01/2014
Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer research	Q Long, J Xu, AO Osunkoya, S Sannigrahi, BA Johnson, W Zhou, T Gillespie, JY Park, RK Nam, L Sugar, A Stanimirovic, AK Seth, JA Petros, CS Moreno	06/15/2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of urology	DM Schuster, PT Nieh, AB Jani, R Amzat, FD Bowman, RK Halkar, VA Master, JA Nye, OA Odewole, AO Osunkoya, B Savir-Baruch, P Alaei-Taleghani, MM Goodman	05/01/2014
Idiopathic granulomatous orchitis: morphology and evaluation of its relationship to IgG4 related disease. Human pathology	S Karram, CS Kao, AO Osunkoya, TM Ulbright, JI Epstein	04/01/2014
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clinical transplantation	AB Shrewsberry, AO Osunkoya, K Jiang, R Westby, D Canter, J Pattaras, N Turgeon, VA Master, K Ogan	02/01/2014
Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	KE Fisher, Q Yin-Goen, D Alexis, JS Sirintrapun, W Harrison, R Benjamin Isett, MR Rossi, CS Moreno, AN Young, AO Osunkoya	02/01/2014
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. The American journal of surgical pathology	V Ananthanarayanan, Y Pan, M Tretiakova, MB Amin, L Cheng, JI Epstein, DJ Grignon, DE Hansel, RE Jimenez, JK McKenney, R Montironi, E Oliva, AO Osunkoya, P Rao, VE Reuter, JY Ro, SS Shen, JR Srigley, T Tsuzuki, JL Yao, T Antic, M Haber, JB Taxy, GP Paner	02/01/2014
Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters. International journal of clinical and experimental pathology	L Ehsani, AO Osunkoya	01/01/2014
Metastatic retroperitoneal hemangiopericytoma. The Canadian journal of urology	AD DeRosa, KG Baldie, AO Osunkoya, JG Pattaras	12/01/2013
ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma. Human pathology	H Johnson, M Zhou, AO Osunkoya	10/01/2013
Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions. Molecular imaging and biology	R Amzat, P Taleghani, DL Miller, JJ Beitler, LM Bellamy, JA Nye, W Yu, B Savir-Baruch, AO Osunkoya, Z Chen, WF Auffermann, MM Goodman, DM Schuster	10/01/2013
Schistosomiasis of the prostate: a case report. Analytical and quantitative cytopathology and histopathology	L Ehsani, AO Osunkoya	06/01/2013
Histologic findings on prostate needle core biopsies following cryotherapy as monotherapy for prostatic adenocarcinoma. Human pathology	C Gooden, PT Nieh, AO Osunkoya	05/01/2013
Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases. Analytical and quantitative cytopathology and histopathology	SR Lauer, M Zhou, VA Master, AO Osunkoya	04/01/2013
BCA2 is differentially expressed in renal oncocytoma: an analysis of 158 renal neoplasms. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	L Ehsani, R Seth, S Bacopulos, A Seth, AO Osunkoya	04/01/2013
Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. The Journal of urology	X Yang, C Shao, R Wang, CY Chu, P Hu, V Master, AO Osunkoya, HL Kim, HE Zhau, LWK Chung	02/01/2013
Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. The Journal of biological chemistry	S Zhang, X Wang, S Iqbal, Y Wang, AO Osunkoya, Z Chen, Z Chen, DM Shin, H Yuan, YA Wang, HE Zhau, LW Chung, C Ritenour, O Kucuk, D Wu	01/18/2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. American journal of nuclear medicine and molecular imaging	DM Schuster, PA Taleghani, PT Nieh, VA Master, R Amzat, B Savir-Baruch, RK Halkar, T Fox, AO Osunkoya, CS Moreno, JA Nye, W Yu, B Fei, Z Wang, Z Chen, MM Goodman	01/01/2013
An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation. BioMed research international	RS Arnold, Q Sun, CQ Sun, JC Richards, S O'Hearn, AO Osunkoya, DC Wallace, JA Petros	01/01/2013
CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	MJ Lee, AP Vogt, W Hsiao, AO Osunkoya	12/01/2012
Mucin-producing tumors and tumor-like lesions involving the prostate: a comprehensive review. Advances in anatomic pathology	KD Bohman, AO Osunkoya	11/01/2012
Biological Interpretation of Morphological Patterns in Histopathological Whole-Slide Images. ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine	S Kothari, JH Phan, AO Osunkoya, MD Wang	10/01/2012
Clear cell, papillary and chromophobe renal cell carcinoma in patients younger than 20 years old: a clinicopathologic study with follow-up. Journal of pediatric urology	J Wang, BM Shehata, SM Langness, GK Davis, L Cheng, AO Osunkoya	10/01/2012
A rare case of solitary metastatic non-seminomatous malignant germ cell tumor to the prostate. The Canadian journal of urology	RW Dobbs, AO Osunkoya, PT Nieh, DJ Canter	10/01/2012
Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer. The Prostate	M Goodman, KC Ward, AO Osunkoya, MW Datta, D Luthringer, AN Young, K Marks, V Cohen, JC Kennedy, MJ Haber, MB Amin	09/15/2012
A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Prostate cancer and prostatic diseases	DM Marcus, M Goodman, AB Jani, AO Osunkoya, PJ Rossi	09/01/2012
Update on prostate pathology. Pathology	AO Osunkoya	08/01/2012
Practical issues and pitfalls in staging tumors of the genitourinary tract. Seminars in diagnostic pathology	AO Osunkoya, DJ Grignon	08/01/2012
Hyperspectral imaging and quantitative analysis for prostate cancer detection. Journal of biomedical optics	H Akbari, LV Halig, DM Schuster, A Osunkoya, V Master, PT Nieh, GZ Chen, B Fei	07/01/2012
Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini. Pathology	EC Chastain, IV Oliva, AO Osunkoya	04/01/2012
ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. American journal of physiology. Cell physiology	C Duran, Z Qu, AO Osunkoya, Y Cui, HC Hartzell	02/01/2012
Pelvic nephroureterectomy for renal cell carcinoma in an ectopic kidney. Case reports in oncological medicine	KG Baldie, UA Al-Qassab, CW Ritenour, MM Issa, AO Osunkoya, JA Petros	01/01/2012
Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement. International journal of clinical and experimental pathology	MD Reid, AO Osunkoya, MT Siddiqui, SW Looney	01/01/2012
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene	S Zhang, X Wang, AO Osunkoya, S Iqbal, Y Wang, Z Chen, S Müller, Z Chen, S Josson, IM Coleman, PS Nelson, YA Wang, R Wang, DM Shin, FF Marshall, O Kucuk, LW Chung, HE Zhau, D Wu	12/15/2011
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology	TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master	10/01/2011
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. The American journal of pathology	Q Long, BA Johnson, AO Osunkoya, YH Lai, W Zhou, M Abramovitz, M Xia, MB Bouzyk, RK Nam, L Sugar, A Stanimirovic, DJ Williams, BR Leyland-Jones, AK Seth, JA Petros, CS Moreno	07/01/2011
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	S Ali, Q Yin-Goen, TV Johnson, W Han, NA Johnson, WB Harris, FF Marshall, AN Young, VA Master, AO Osunkoya	04/01/2011
E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	MG Lim, NV Adsay, DJ Grignon, AO Osunkoya	02/01/2011
Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome? Human pathology	IV Oliva, SL Smith, Z Chen, AO Osunkoya	01/01/2011
Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases. International journal of urology : official journal of the Japanese Urological Association	N Edgerton, SJ Sirintrapun, M Munoz, Z Chen, AO Osunkoya	01/01/2011
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PloS one	HW Lue, X Yang, R Wang, W Qian, RZ Xu, R Lyles, AO Osunkoya, BP Zhou, RL Vessella, M Zayzafoon, ZR Liu, HE Zhau, LW Chung	01/01/2011
An unusual presentation of a mixed epithelial and stromal tumor in an elderly male. TheScientificWorldJournal	KA Moses, IV Oliva, AO Osunkoya, KJ Carney	09/14/2010
Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding? Human pathology	AP Vogt, Z Chen, AO Osunkoya	09/01/2010
Endometrioid adenocarcinoma in the native ureter of a renal transplant patient: case report and review of the literature. TheScientificWorldJournal	KA Healy, KJ Carney, AO Osunkoya	09/01/2010
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology	TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master	09/01/2010
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast cancer research and treatment	TR Graham, R Yacoub, L Taliaferro-Smith, AO Osunkoya, VA Odero-Marah, T Liu, KS Kimbro, D Sharma, RM O'Regan	08/01/2010
C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma. Molecular diagnosis & therapy	TV Johnson, AN Young, AO Osunkoya, VA Master	06/01/2010
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS nano	J Liu, SK Lau, VA Varma, RA Moffitt, M Caldwell, T Liu, AN Young, JA Petros, AO Osunkoya, T Krogstad, B Leyland-Jones, MD Wang, S Nie	05/25/2010
Tubulocystic carcinoma of the kidney: a case report of natural history and long-term follow-up. TheScientificWorldJournal	KA Moses, JJ Decaro, AO Osunkoya, MM Issa	04/01/2010
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology	RS Arnold, NV Makarova, AO Osunkoya, S Suppiah, TA Scott, NA Johnson, SM Bhosle, D Liotta, E Hunter, FF Marshall, H Ly, RJ Molinaro, JL Blackwell, JA Petros	04/01/2010
Localized cystic disease of the kidney: an unusual entity that can mimic a cystic neoplasm. American journal of kidney diseases : the official journal of the National Kidney Foundation	EE Dowden, AO Osunkoya, DA Baumgarten	03/01/2010
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Molecular cancer	S Zhang, HE Zhau, AO Osunkoya, S Iqbal, X Yang, S Fan, Z Chen, R Wang, FF Marshall, LW Chung, D Wu	01/19/2010
Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis. Human pathology	AO Osunkoya, Q Yin-Goen, JH Phan, RA Moffitt, TH Stokes, MD Wang, AN Young	12/01/2009
Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	M Lim, NV Adsay, D Grignon, AO Osunkoya	10/01/2009
Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	SD Schniederjan, AO Osunkoya	08/01/2009
Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. The American journal of surgical pathology	AO Osunkoya, AN Young, W Wang, GJ Netto, JI Epstein	07/01/2009
Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Human pathology	AO Osunkoya, C Cohen, D Lawson, MM Picken, MB Amin, AN Young	02/01/2009
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. The Prostate	RS Arnold, CQ Sun, JC Richards, G Grigoriev, IM Coleman, PS Nelson, CL Hsieh, JK Lee, Z Xu, A Rogatko, AO Osunkoya, M Zayzafoon, L Chung, JA Petros	01/01/2009
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. Journal of translational medicine	CD Scharer, N Laycock, AO Osunkoya, S Logani, JF McDonald, BB Benigno, CS Moreno	12/11/2008
The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 cases. Pathology	AO Osunkoya, DE Hansel, AV Parwani, TZ Ali, EF Tamas, VG Untawale, H Kahane, JI Epstein	08/01/2008
MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	AO Osunkoya, NV Adsay, C Cohen, JI Epstein, SL Smith	07/01/2008
Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer research	TR Graham, HE Zhau, VA Odero-Marah, AO Osunkoya, KS Kimbro, M Tighiouart, T Liu, JW Simons, RM O'Regan	04/01/2008
Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases. The American journal of surgical pathology	AO Osunkoya, ME Nielsen, JI Epstein	03/01/2008

Awards

Dr. Osunkoya has received numerous awards including the prestigious Benjamin Castleman Award from the United States and Canadian Academy of Pathology, the Golden Apple Award for Excellence in Resident Education from the Department of Pathology of Emory University School of Medicine, and the Young Investigator Award in Clinical Research from the Department of Pathology of The Johns Hopkins Hospital. As chief resident at University of Oklahoma Health Sciences center, Dr. Osunkoya received the Perry Lambird Award for Outstanding Resident in Clinical Pathology, the Parker-Heartland Award for Outstanding Resident in Anatomic Pathology, and the Nancy K. Hall Award for Most Outstanding First Year Resident from the Department of Pathology. Dr. Osunkoya has also been named a Donald West King Fellow of the Gastrointestinal Pathology Division of the Armed Forces Institute of Pathology and was an invited speaker for the 20th Anniversary of the International Society of Urological Pathology in Vancouver in 2012.

Dr. Osunkoya also received the prestigious Arthur Purdy Stout Prize, one of the top honors in surgical pathology in North America.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.